Clinical Trials List
2017-01-18 - 2020-04-30
Phase III
Terminated3
ICD-9150.8
Malignant neoplasm of other specified part of esophagus
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Nai-Jung Chiang Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Yau-Lin Tseng Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Yu-Sen Lin Division of Thoracic Surgery
- 方信元 Division of Thoracic Surgery
- Yao-Ching Wang Division of Radiation Therapy
- 林昱森醫師 Division of Thoracic Surgery
- Chun-Ru Chien Division of Radiation Therapy
- Ming-Yu Lien Division of Hematology & Oncology
- 王耀慶醫師 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- JANG-MING LEE Division of Thoracic Surgery
- JHE-CYUAN GUO Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 黃培銘 Division of General Surgery
- Kun-Huei Yeh Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
760 participants
